Market Overview

Loxo Oncology (NASDAQ: )

0.00 0.00 (0.00%)

Earnings

QuarterPriorEstimateActualSurprise
Q3 2018
Pre-Market
EPS:
REV:
-0.94
-0.85
36.6M
-0.89
42.47M
4.71%
16.04%
Q2 2018
Pre-Market
EPS:
REV:
-0.94
-0.54
28.91M
-1.68
42.601M
211.11%
47.36%
Q1 2018
Pre-Market
EPS:
REV:
-0.96
-0.72
16.46M
-0.12
38.429M
-83.33%
133.47%
Q4 2017
Pre-Market
EPS:
REV:
-1.27
-1.15
-0.69
21.3M
-40%
Q3 2017
Pre-Market
EPS:
REV:
-0.82
-1.26
-2.45
94.44%
Q2 2017
Pre-Market
EPS:
REV:
-0.77
-0.98
-1.14
16.33%
Q1 2017
Pre-Market
EPS:
REV:
-0.59
-0.88
-0.96
9.09%
Q4 2016
Pre-Market
EPS:
REV:
-0.73
-0.85
-1.27
49.41%
Q3 2016
Pre-Market
EPS:
REV:
-0.53
-0.74
-0.82
-1081.08%
Q2 2016
Pre-Market
EPS:
REV:
-0.49
-0.63
-0.77
-22.22%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!